Ascension CEO will step down at end of 2019

After a 15-year stint as the CEO of nonprofit health system Ascension, Anthony R. Tersigni, EdD, announced he’s stepping down from his role at the end of 2019.

Tersigni became president and CEO of Ascension Health in 2004 after serving as its chief operating officer since 2001, according to a statement. When Ascension was formed in 2012 as the parent organization of Ascension Health and its direct subsidiaries, Tersigni was the healthcare system’s first president and CEO.

He plans to relinquish control of Ascension Dec. 31, after which point he’ll continue to serve on Ascension’s healthcare investment fund executive committee and act as a consultant for the institution on an ongoing basis.

Stephen M. Dufilho, chair of Ascension’s board of directors, said in the statement Tersigni has been key to the development of a strategic plan that emphasizes extending healthcare to individuals in need and expanding the scope of Ascension’s reach.

“Never content to simply keep up with external trends, Tony has focused his time and energy on innovating and creating the future—leading transformation at Ascension to enable our mission of serving all persons with special attention to those who are poor and vulnerable,” Dufilho wrote.

The announcement of Tersigni’s retirement comes just two months after three high-ranking executives at Ascension confirmed they’d be leaving their roles. CEO of Ascension Healthcare, Patricia Maryland, DrPH, will be leaving after June; Joseph Impicciche, JD, MHA, will assume the newly created president/COO position in July; and John Doyle, executive vice president of Ascension, announced he’d be retiring come Dec. 31.

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”